NEW YORK (GenomeWeb News) – Newfoundland and Labrador's Research & Development Corp., announced on Tuesday the investment of more than C$5.3 million (US$5.4 million) into 33 projects, including several 'omics projects, at Memorial University Newfoundland.
The investment is provided through RDC's academic programs focusing on building the R&D capacity in support of innovation and commercialization within the province. R&D is a provincial Crown corporation charged with improving Newfoundland and Labrador's R&D performance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.